Educational, research-use-only content. This article summarizes published scientific literature for informational purposes only and is not medical advice. The compounds discussed are supplied strictly for in-vitro laboratory research and are not approved for human or veterinary use.
What is 5-amino-1MQ?
5-amino-1MQ is a small-molecule inhibitor of the enzyme nicotinamide N-methyltransferase (NNMT). It is studied as a research tool for probing energy metabolism and fat-tissue biology (Sun et al., 2024).
What the research describes
NNMT has emerged as a target of interest in metabolic-syndrome research. A review notes that elevated NNMT is observed in liver and white adipose tissue in obesity and diabetes models, and that knocking down NNMT increased energy expenditure, reduced lipid accumulation, and improved insulin sensitivity in animal studies. NNMT consumes nicotinamide (an NAD+ precursor), so its inhibition is studied for downstream effects on NAD+ metabolism (Sun et al., 2024).
The limits of the current evidence
- The supportive data are preclinical (cell and animal); the review explicitly notes that no clinical trials targeting NNMT have been documented.
- 5-amino-1MQ is not an approved medicine; this material is for laboratory research use only.
References
According to PubMed:
- Sun WD, et al. Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome. Front Pharmacol. 2024. doi:10.3389/fphar.2024.1410479
